Last reviewed · How we verify

NCT06661863

Effectiveness of Alveolar Bone Preservation in Alveoli With Infectious Process

Not yet recruiting NA Last updated 28 October 2024
What this trial tests

NA trial testing alveolar ridge preservation with bioactive glass in Alveolar Bone Loss in 28 participants. Not yet recruiting.

Timeline
15 November 2024
Primary endpoint
15 December 2024
15 December 2029

Quick facts

Lead sponsorUniversidad de Especialidades Espiritu Santo
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment28
Start date15 November 2024
Primary completion15 December 2024
Estimated completion15 December 2029
Sites1 location across Ecuador

Drugs / interventions tested

Conditions studied

Sponsor

Universidad de Especialidades Espiritu Santo

Who can join

18 and older, any sex, with Alveolar Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Alveolar ridge preservation (ARP) is a surgical technique that aims to minimize the degree of dimensional changes following extraction. In the healing period after extraction, the alveolar bone (AB) undergoes morphological changes during the remodeling process. The changes become evident immediately after tooth extraction, with greater resorption changes observed during the first two months, and these dimensional changes can be observed 1 year after surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Alveolar Bone Loss

Currently open trials in the same condition.

Other Universidad de Especialidades Espiritu Santo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06661863.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing